Psychotic Disorders Archives - Page 2 of 3

What is the HCR-20? – Historical Clinical and Risk Management 20

April 7, 2017

The Historical, Clinical and Risk Management – 20 (HCR -20) is a structured tool to assess the risk of violence. The items are below. Historical items H1 Violence As a child (under 12 years) As an adolescent (13-17 years) As an adult (18 and over)…

Niemann Pick Type C – What Can a Neurometabolic Disorder Tell Us About The Underlying Pathophysiology of Schizophrenia?

April 3, 2017

In the last decade another neurometabolic disorder has been increasingly recognized as a cause of “secondary” schizophrenia. Niemann-Pick disease type C (NPC) is a recessive neurovisceral disorder affecting intracellular cholesterol trafficking, and occurs in 1:100,000 individuals in a pan ethnic distribution. Dysfunction of the NPC1…

Managing Metabolic Syndrome and The ‘It’s My Son Test’- Conversations with Dr Stephen Stahl

March 20, 2017

This interview is the fifth as part of a series of brief interviews where Dr Sanil Rege talks to Dr Stephen Stahl about key issues that face psychiatry and our patients. Dr Stahl, MD, is a practicing Psychiatrist in Carlsbad, USA, and author of the…

A Journey on the Metabolic Highway – Conversations with Dr Stephen Stahl

February 23, 2017

This interview is the fourth as part of a series of brief interviews where Dr Sanil Rege talks to Dr Stephen Stahl about key issues that face psychiatry and our patients. Dr Stahl, MD, is a practising Psychiatrist in Carlsbad, USA, and author of the…

Cognitive Behavioral Therapy Changes Brain Connectivity Predicting Long Term Recovery in Psychosis

February 9, 2017

This longitudinal study involved 56 outpatients (54 with paranoid schizophrenia and 2 with schizoaffective disorder) who had no history of head injuries or neurological conditions. All patients were on a stable dose of antipsychotics and had been for over 2 years. The patients were equally…

N-Acetylcysteine (NAC) in Schizophrenia and Bipolar Disorder- Prof Michael Berk

December 15, 2016

Professor Michael Berk is currently an NHMRC Senior Principal Research Fellow and is Alfred Deakin Chair of Psychiatry at Deakin University and Barwon Health, where he heads the IMPACT Strategic Research Centre. He also is an Honorary Professorial Research Fellow in the Department of Psychiatry,…

The Metabolic Syndrome in Psychiatry and The Triple Whammy Effect – Conversations with Dr Stephen Stahl

November 21, 2016

This interview is the first as part of a series of brief interviews where Dr. Sanil Rege talks to Dr. Stephen Stahl about key issues that face psychiatry and our patients. Dr. Stahl, MD, is a practicing Psychiatrist in Carlsbad, USA, and author of the…

Glutathione, Oxidative Stress and N-Acetylcysteine (NAC) in Psychiatric Disorders – Prof Michael Berk

October 30, 2016

Prof Jayashri Kulkarni’s Tips On Prescribing Antipsychotics in Pregnancy

August 14, 2016

Prof Jayashri Kulkarni takes us through the key points for clinicians to remember in prescribing antipsychotics in women of childbearing age and pregnant women. Summary: Second Generation Antipsychotics (SGA’s) are used in a wide variety of conditions such as Schizophrenia, Bipolar Affective Disorder, Anxiety Disorders…

Déjà Phenomenon

June 22, 2016

Déjà entendu: Illusion that what one is hearing has been heard previously. Déjà vu’: New situation is recognised incorrectly as a repetition of previous experience. Déjà pense’: condition in which a thought never entertained before is incorrectly regarded as a repetition of a previous thought.…

PSYCHOTIC DISORDERS